A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
To speed progress against cancer and other diseases, the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project today announced the largest-ever release of comprehensive human cancer genome data for free access by the global scientific community. The amount of information released more than doubles the volume of high-coverage, whole genome data currently available from all human genome sources combined. This information is valuable not just to cancer researchers, but also to scientists studying almost any disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52993-st-jude-childrens-research-hospital-comprehensive-human-cancer-genome-data
St. Jude Children’s Research Hospital®, uno de los principales centros de investigación y tratamiento del cáncer pediátrico se unió a Univision Radio, la mayor difusora de radio Hispana en los Estados Unidos, para realizar su evento radial anual Promesa y Esperanza®. Los radioyentes alrededor del país sintonizaron su estación favorita de Univision Radio el 7 y 8 de febrero y recaudaron más de $5.3 millones en efectivo y promesas monetarias. Los fondos recaudados ayudarán a cubrir los gastos de investigación y tratamiento del cáncer pediátrico y otras enfermedades terminales en los Estados Unidos, Puerto Rico y alrededor del mundo.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58260-st-jude-childrens-research-hospital-univision-radio-promesa-y-esperanza
Go on an adventure with Ricky Ricotta’s Mighty Robot vs. the Uranium Unicorns from Uranus! From Dav Pilkey, the creator of Captain Underpants, and Dan Santat, the creator Sidekicks! Childrens
Inspired by Ole Henriksen’s passion for helping people, OLEHENRIKSEN introduces a limited-edition Luxury-size Truth Serum for Holiday 2017 in partnership with Starlight Children’s Foundation, a 501 (c)(3) organization whose mission is to bring joy and comfort to hospitalized children and their families. For every OLEHENRIKSEN Luxury-size Truth Serum sold, the brand will donate 10% of the proceeds to the Starlight Brave Gowns Program, which replaces unattractive and uncomfortable hospital garments with high-quality, comfortable and brightly colored gowns.
Starlight Brave Gowns transform children into astronauts, cowboys and other characters, empowering them to have fun and enjoy being kids during their hospital stays, especially during the holiday season. Best of all, OLEHENRIKSEN has also designed a bright and colorful child-friendly hospital Starlight Brave Gown, and the sale of each Luxury-size Truth Serum will help in gifting these gowns and the Ole Glow® to the Starlight Children’s Foundation.
To view the multimedia release go to:
https://www.multivu.com/players/English/8215851-olehenriksen-partners-with-starlight-childrens-foundation/
A contemporary parable about a big red tractor and a long lost instruction book teaches children that God has a purpose they can fulfill through His Spirit. A little boy learns the importance of honesty and of living whole heartedly for God. Learn more about the Big Red Tractor: http://bit.ly/cK5K4j Learn more about Halfway Herbert: http://bit.ly/b9MPpw Learn more about the author: http://bit.ly/bpndcf Juvenile Fiction/Religious/Christian/Early Readers
Readers' Favorite provides authors with a FREE review of their published or unpublished book, manuscript, eBook, audio book, comic book or poetry book.
The Procter & Gamble Company (NYSE: PG) support for the relief and rebuilding efforts in Haiti now totals over $2 million.
P&G product donations total more than $1.2 million with cash and donations from P&G, its employees and retirees, taking the total over $2 million. Product donations include bar soaps, batteries, bleach, diapers, dish detergents, feminine hygiene products, flashlights, laundry detergents, paper towels, shampoos, toilet tissue, tooth brushes, toothpaste, and wipes. Additionally, P&G has committed to providing six million packets of PUR, a technology that purifies contaminated water. This quantity is enough to treat 60 million liters of water (a 3-month supply for 340,000 people).
To view Multimedia News Release go to, http://multivu.prnewswire.com/mnr/pg/42295/
Former University of Texas great Colt McCoy is teaming up with Scott & White Healthcare as part of a philanthropic initiative to raise $50 million for a planned regional children’s hospital. The collaboration was announced today at a reception for hospital officials and donors at Scott & White Hospital in Temple.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sw/45124/
Lancôme is unveiling Genes Day on October 22, a one day fundraiser in support of St. Jude Children’s Research Hospital.
In celebration of the beauty of scientific research, Lancôme will donate $7 from each bottle of their latest skin care breakthrough, Génifique Youth Activating Concentrate, sold that day to St. Jude Children’s Research Hospital to support the research and treatment at St. Jude.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lancome/46646/
An inaugural national research report released today from The Children’s Hospital of Philadelphia (CHOP) and State Farm Insurance Companies® shows that the impact of teen driver crashes extends far beyond teen drivers’ families and friends. In 2008, more than half a million (681,000) people were involved in crashes where a teen driver was behind the wheel. More than 40,000 were injured, and nearly 30 percent of those who died in these crashes were not in cars driven by teens.
To view Multimedia News Release, go to http://www.multivu.com/players/English/47737-Miles-to-Go-Teen-Driver-Safety/
